Neuron23, Inc.
- Biotech or pharma, therapeutic R&D
Neuron23™ Inc. is a clinical stage biotechnology company developing precision medicines for genetically defined neurological and immunological diseases, with lead programs targeting LRRK2, peripherally-restricted TYK2, and brain penetrant TYK2.